Diagnosis of Dengue in a returning traveler from Pakistan suspected of COVID-19, California, USA

Philip L Bulterys; Daniel Solis; Michelle Verghese; Chunhong Huang; Mamdouh Sibai; Cristina Costales; Malaya K Sahoo; Benjamin A Pinsky

doi:10.1016/j.diagmicrobio.2021.115517

Diagnosis of Dengue in a returning traveler from Pakistan suspected of COVID-19, California, USA

Diagn Microbiol Infect Dis. 2021 Dec;101(4):115517. doi: 10.1016/j.diagmicrobio.2021.115517. Epub 2021 Aug 6.

Authors

Philip L Bulterys¹, Daniel Solis², Michelle Verghese², Chunhong Huang², Mamdouh Sibai², Cristina Costales¹, Malaya K Sahoo², Benjamin A Pinsky³

Affiliations

¹ Department of Pathology, Stanford University, Stanford, CA, USA.
² Department of Pathology, Stanford University, Stanford, CA, USA; Clinical Virology Laboratory, Stanford University Medical Center, Stanford, CA, USA.
³ Department of Pathology, Stanford University, Stanford, CA, USA; Clinical Virology Laboratory, Stanford University Medical Center, Stanford, CA, USA; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: [email protected].

Abstract

Dengue and COVID-19 cocirculation presents a diagnostic conundrum for physicians evaluating patients with acute febrile illnesses, both in endemic regions and among returning travelers. We present a case of a returning traveler from Pakistan who, following repeated negative SARS-CoV-2 tests, was found to have a Dengue virus serotype 2 infection.

Keywords: COVID-19; Dengue Virus; Dengue fever; Returning traveler; SARS-CoV-2.

Publication types

Case Reports

MeSH terms

Adult
COVID-19 / diagnosis*
COVID-19 / epidemiology
California / epidemiology
Dengue / diagnosis*
Dengue / epidemiology
Dengue Virus / classification
Dengue Virus / genetics
Female
Genome, Viral
Humans
Pakistan / epidemiology
Phylogeny
Reverse Transcriptase Polymerase Chain Reaction
SARS-CoV-2*
Serogroup
Travel